April 30, 2020 / 12:31 PM / in a month

BRIEF-Zentalis Pharmaceuticals Announces FDA Clearance Of IND Application For Treatment Of Hematologic Malignancies

April 30 (Reuters) - Zentalis Pharmaceuticals Inc:

* ZENTALIS PHARMACEUTICALS ANNOUNCES FDA CLEARANCE OF IND APPLICATION FOR ZN-D5 FOR THE TREATMENT OF HEMATOLOGIC MALIGNANCIES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below